Envoy Medical, Inc. COCH
7.12 USD 0.00 (+0.00%)
At closeNov 5, 2026, 9:02 AM EST
7.19 +0.07 +0.98%
Pre-market · Nov 5, 9:02 AM ET
Day range unavailable
3.63 52-week range 9.54
- YTD
- +7.72%
- 1 year
- -1.79%
Analyst view
Price target (mean) 6.50 -8.7% downside
Now 7.12
- Target (low)
- 5.00
- Target (mean)
- 6.50
- Target (high)
- 9.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy0
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 4
- 2 months ago 4
- 3 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.31333 | -0.36 – -0.25 | 0.00 | 0.0% | 77.50K | -18.4% | 3 |
| Next quarter | -0.34333 | -0.42 – -0.28 | -0.32 | -7.3% | 78.33K | +32.8% | 3 |
| Current year | -1.28 | -1.33 – -1.21 | -2.38 | +46.2% | 258.75K | -18.1% | 3 |
| Next year | -1.26 | -1.39 – -1.15 | -1.28 | +1.6% | 325.00K | +25.6% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 6, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Oct 14, 2024 | Brookline Capital | Initiated | — | Buy |
| Sep 3, 2024 | Ascendiant Capital | Maintained | Buy | Buy |
| Jun 24, 2024 | Ascendiant Capital | Initiated | — | Buy |
| Apr 3, 2024 | Lake Street | Maintained | Buy | Buy |
| Dec 21, 2023 | Northland Capital Markets | Initiated | — | Outperform |
| Nov 28, 2023 | Lake Street | Initiated | — | Buy |